| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
900 |
700,649 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-02-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
43 |
700,606 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2014-02-26 |
4 |
OE |
$1.23 |
$4,605,236 |
I/I |
3,744,094 |
13,233,640 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-19 |
4 |
S |
$1.91 |
$836,809 |
D/D |
(438,120) |
6,919,392 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-20 |
4 |
S |
$1.90 |
$219,435 |
D/D |
(115,492) |
6,803,900 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-21 |
4 |
S |
$1.79 |
$1,143,164 |
D/D |
(638,639) |
6,165,261 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-04-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
44 |
700,562 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-04-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
44 |
700,518 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-02 |
4 |
OE |
$16.80 |
$9,868,337 |
I/I |
587,401 |
9,776,920 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
30 |
700,488 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-19 |
4 |
A |
$16.80 |
$14,499,610 |
I/I |
863,072 |
10,639,992 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-06-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
37 |
700,451 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-06-30 |
4 |
B |
$26.09 |
$260,900 |
I/I |
10,000 |
10,649,992 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-01 |
4 |
B |
$25.70 |
$223,539 |
I/I |
8,698 |
10,658,690 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-16 |
4 |
B |
$19.89 |
$397,800 |
I/I |
20,000 |
10,678,690 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-08-21 |
4 |
B |
$16.79 |
$48,691 |
I/I |
2,900 |
10,681,590 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-08-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
40 |
700,411 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-08-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,688 |
698,723 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-18 |
4 |
B |
$16.80 |
$8,417 |
I/I |
501 |
10,682,091 |
2.17 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-19 |
4 |
B |
$16.67 |
$531,940 |
I/I |
31,910 |
10,714,001 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-22 |
4 |
B |
$16.44 |
$42,547 |
I/I |
2,588 |
10,716,589 |
2.25 |
- |
|
| BIOL |
Biolase Inc |
|
– – – |
2014-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,604,166 |
|
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
345 |
698,378 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,028 |
697,350 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
62 |
697,288 |
0 |
- |
|
634 Records found
|
|
Page 8 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
